Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cytochrome b pseudogene is a nuclear DNA sequence derived from the mitochondrial cytochrome b gene via translocation (NUMT, nuclear mitochondrial DNA segment). It accumulates mutations, indels, and frame-shifts that render it non-functional, and it cannot be translated into an active protein. These pseudogenes can be accidentally amplified during molecular genetic studies, potentially leading to analytical errors. While originally considered non-functional, some pseudogenes (including cytochrome b pseudogene) may play regulatory roles as non-coding RNA in cellular networks such as the ceRNA network. This pseudogene is not considered a therapeutic target and has no known drug interactions, but must be appropriately identified to avoid confusion in genetic or biomarker studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b pseudogene.